Cargando…
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Several studies have been in favor of fungi as a possible pathogenesis of chronic rhinosinusitis (CRS); however, to date, there is no scientific consensus about the use of antifungal agents in disease management. The aim of the present study was to investigate the efficacy of intranasal fluconazole...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822190/ https://www.ncbi.nlm.nih.gov/pubmed/27065776 http://dx.doi.org/10.17179/excli2015-678 |
_version_ | 1782425730694512640 |
---|---|
author | Hashemian, Farshad Hashemian, Farnaz Molaali, Najmeh Rouini, Mohammadreza Roohi, Elnaz Torabian, Saadat |
author_facet | Hashemian, Farshad Hashemian, Farnaz Molaali, Najmeh Rouini, Mohammadreza Roohi, Elnaz Torabian, Saadat |
author_sort | Hashemian, Farshad |
collection | PubMed |
description | Several studies have been in favor of fungi as a possible pathogenesis of chronic rhinosinusitis (CRS); however, to date, there is no scientific consensus about the use of antifungal agents in disease management. The aim of the present study was to investigate the efficacy of intranasal fluconazole in improving disease symptoms and objective outcomes of patients with CRS. A randomized, double-blind, placebo-controlled study was conducted on 54 patients who were diagnosed with CRS and had not been responsive to routine medical treatments. They were randomly assigned to receive either fluconazole nasal drop 0.2 % or placebo in addition to the standard regimen for a duration of 8 weeks. Patients' outcomes were evaluated according to Sino-Nasal Outcome Test 20 (SNOT-20), endoscopic scores, and Computed Tomography (CT) scores. No statistically significant difference was found in SNOT-20 (p = 0.201), endoscopic (p = 0.283), and CT scores (p = 0.212) of the patients at baseline and after 8-week course of treatment between drug and placebo group. Similar to many studies, the use of topical antifungal treatment for patients with CRS was not shown to be significantly effective. However, further studies are needed to obtain high levels of consistent evidence in order to arrive at a decision whether antifungal therapy is effective in management of CRS or not. |
format | Online Article Text |
id | pubmed-4822190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Leibniz Research Centre for Working Environment and Human Factors |
record_format | MEDLINE/PubMed |
spelling | pubmed-48221902016-04-08 Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole Hashemian, Farshad Hashemian, Farnaz Molaali, Najmeh Rouini, Mohammadreza Roohi, Elnaz Torabian, Saadat EXCLI J Original Article Several studies have been in favor of fungi as a possible pathogenesis of chronic rhinosinusitis (CRS); however, to date, there is no scientific consensus about the use of antifungal agents in disease management. The aim of the present study was to investigate the efficacy of intranasal fluconazole in improving disease symptoms and objective outcomes of patients with CRS. A randomized, double-blind, placebo-controlled study was conducted on 54 patients who were diagnosed with CRS and had not been responsive to routine medical treatments. They were randomly assigned to receive either fluconazole nasal drop 0.2 % or placebo in addition to the standard regimen for a duration of 8 weeks. Patients' outcomes were evaluated according to Sino-Nasal Outcome Test 20 (SNOT-20), endoscopic scores, and Computed Tomography (CT) scores. No statistically significant difference was found in SNOT-20 (p = 0.201), endoscopic (p = 0.283), and CT scores (p = 0.212) of the patients at baseline and after 8-week course of treatment between drug and placebo group. Similar to many studies, the use of topical antifungal treatment for patients with CRS was not shown to be significantly effective. However, further studies are needed to obtain high levels of consistent evidence in order to arrive at a decision whether antifungal therapy is effective in management of CRS or not. Leibniz Research Centre for Working Environment and Human Factors 2016-02-05 /pmc/articles/PMC4822190/ /pubmed/27065776 http://dx.doi.org/10.17179/excli2015-678 Text en Copyright © 2016 Hashemian et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited. |
spellingShingle | Original Article Hashemian, Farshad Hashemian, Farnaz Molaali, Najmeh Rouini, Mohammadreza Roohi, Elnaz Torabian, Saadat Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
title | Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
title_full | Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
title_fullStr | Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
title_full_unstemmed | Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
title_short | Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
title_sort | clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822190/ https://www.ncbi.nlm.nih.gov/pubmed/27065776 http://dx.doi.org/10.17179/excli2015-678 |
work_keys_str_mv | AT hashemianfarshad clinicaleffectsoftopicalantifungaltherapyinchronicrhinosinusitisarandomizeddoubleblindplacebocontrolledtrialofintranasalfluconazole AT hashemianfarnaz clinicaleffectsoftopicalantifungaltherapyinchronicrhinosinusitisarandomizeddoubleblindplacebocontrolledtrialofintranasalfluconazole AT molaalinajmeh clinicaleffectsoftopicalantifungaltherapyinchronicrhinosinusitisarandomizeddoubleblindplacebocontrolledtrialofintranasalfluconazole AT rouinimohammadreza clinicaleffectsoftopicalantifungaltherapyinchronicrhinosinusitisarandomizeddoubleblindplacebocontrolledtrialofintranasalfluconazole AT roohielnaz clinicaleffectsoftopicalantifungaltherapyinchronicrhinosinusitisarandomizeddoubleblindplacebocontrolledtrialofintranasalfluconazole AT torabiansaadat clinicaleffectsoftopicalantifungaltherapyinchronicrhinosinusitisarandomizeddoubleblindplacebocontrolledtrialofintranasalfluconazole |